Timing of multikinase inhibitor initiation in differentiated thyroid cancer.
about
Advances in small molecule therapy for treating metastatic thyroid cancer.Updates on the Management of Advanced, Metastatic, and Radioiodine Refractory Differentiated Thyroid Cancer.Thyroglobulin “Nonsecretor” Metastatic Poorly Differentiated Thyroid Carcinoma with Noniodine Concentrating Disease and Aggressive Clinical Course: A Clinical Case Series.Long-term efficacy of lenvatinib for recurrent papillary thyroid carcinoma after multimodal treatment and management of complications: a case report.Navigating Systemic Therapy in Advanced Thyroid Carcinoma: From Standard of Care to Personalized Therapy and Beyond
P2860
Timing of multikinase inhibitor initiation in differentiated thyroid cancer.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Timing of multikinase inhibitor initiation in differentiated thyroid cancer.
@ast
Timing of multikinase inhibitor initiation in differentiated thyroid cancer.
@en
type
label
Timing of multikinase inhibitor initiation in differentiated thyroid cancer.
@ast
Timing of multikinase inhibitor initiation in differentiated thyroid cancer.
@en
prefLabel
Timing of multikinase inhibitor initiation in differentiated thyroid cancer.
@ast
Timing of multikinase inhibitor initiation in differentiated thyroid cancer.
@en
P2093
P2860
P356
P1476
Timing of multikinase inhibitor initiation in differentiated thyroid cancer.
@en
P2093
Chia-Chi Lin
Iwao Sugitani
Johannes Smit
Marc Fellous
Marcia S Brose
Martin Schlumberger
Masayuki Tori
Yoriko DeSanctis
P2860
P304
P356
10.1530/ERC-17-0016
P577
2017-03-07T00:00:00Z